Mihajlovic Milos, Krebber Merle M, Yang Yi, Ahmed Sabbir, Lozovanu Valeria, Andreeva Daria, Verhaar Marianne C, Masereeuw Rosalinde
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands.
Department Nephrology and Hypertension, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Biomedicines. 2021 Sep 26;9(10):1326. doi: 10.3390/biomedicines9101326.
Protein bound-uremic toxins (PBUTs) are not efficiently removed by hemodialysis in chronic kidney disease (CKD) patients and their accumulation leads to various co-morbidities via cellular dysfunction, inflammation and oxidative stress. Moreover, it has been shown that increased intrarenal expression of the NLRP3 receptor and IL-1β are associated with reduced kidney function, suggesting a critical role for the NLRP3 inflammasome in CKD progression. Here, we evaluated the effect of PBUTs on inflammasome-mediated IL-1β production in vitro and in vivo. Exposure of human conditionally immortalized proximal tubule epithelial cells to indoxyl sulfate (IS) and a mixture of anionic PBUTs (UT mix) increased expression levels of NLRP3, caspase-1 and IL-1β, accompanied by a significant increase in IL-1β secretion and caspase-1 activity. Furthermore, IS and UT mix induced the production of intracellular reactive oxygen species, and caspase-1 activity and IL-1β secretion were reduced in the presence of antioxidant N-acetylcysteine. IS and UT mix also induced NF-κB activation as evidenced by p65 nuclear translocation and IL-1β production, which was counteracted by an IKK inhibitor. In vivo, using subtotal nephrectomy CKD rats, a significant increase in total plasma levels of IS and the PBUTs, kynurenic acid and hippuric acid, was found, as well as enhanced urinary malondialdehyde levels. CKD kidney tissue showed an increasing trend in expression of NLRP3 inflammasome components, and a decreasing trend in superoxide dismutase-1 levels. In conclusion, we showed that PBUTs induce inflammasome-mediated IL-1β production in proximal tubule cells via oxidative stress and NF-κB signaling, suggesting their involvement in disease-associated inflammatory processes.
蛋白结合尿毒症毒素(PBUTs)在慢性肾脏病(CKD)患者中不能通过血液透析有效清除,其蓄积会通过细胞功能障碍、炎症和氧化应激导致各种合并症。此外,已有研究表明,肾内NLRP3受体和IL-1β表达增加与肾功能降低有关,提示NLRP3炎性小体在CKD进展中起关键作用。在此,我们评估了PBUTs在体外和体内对炎性小体介导的IL-1β产生的影响。将人条件永生化近端肾小管上皮细胞暴露于硫酸吲哚酚(IS)和阴离子PBUTs混合物(UT混合物)中,会增加NLRP3、半胱天冬酶-1和IL-1β的表达水平,同时IL-1β分泌和半胱天冬酶-1活性显著增加。此外,IS和UT混合物诱导细胞内活性氧的产生,在抗氧化剂N-乙酰半胱氨酸存在的情况下,半胱天冬酶-1活性和IL-1β分泌降低。IS和UT混合物还诱导NF-κB活化,p65核转位和IL-1β产生证明了这一点,而IKK抑制剂可抵消这种作用。在体内,使用次全肾切除的CKD大鼠模型发现,血浆中IS和PBUTs、犬尿喹啉酸和马尿酸的总水平显著升高,同时尿丙二醛水平升高。CKD肾组织中NLRP3炎性小体成分的表达呈上升趋势,超氧化物歧化酶-1水平呈下降趋势。总之,我们表明PBUTs通过氧化应激和NF-κB信号通路诱导近端小管细胞中炎性小体介导的IL-1β产生,提示它们参与了疾病相关的炎症过程。